Skip Navigation

SBIR Investor Forum

Accelerate Your Project towards Commercialization at the
2009 NCI SBIR Investor Forum at Boston University

November 5, 2009
8:00 a.m. to 7:00 p.m.

We are pleased to announce the NCI SBIR Investor Forum, a new and exciting event to showcase your innovative cancer-related technology to an elite group of investors and strategic partners. This one-day conference will offer the valuable opportunity for your company to connect with the biotech investment community and potentially secure the necessary funding to bring your product or technology to commercialization.

Apply by September 2, 2009 for the opportunity to be among the select group of small businesses to be featured at the forum.

Highlights include:

  • Present to and network with an estimated 150 investors, members of the pharmaceutical and life sciences industry, and other potential partners
  • Private breakout sessions to meet with potential partners and investors
  • Discussion of the NCI's new funding opportunity, the "SBIR Phase II Bridge Award"
  • Panel session with previous Phase II Bridge awardees and their follow-on investors
  • Opportunities to meet with NCI SBIR Development Center staff to discuss upcoming funding opportunities
  • Keynote presentation by Scott Sarazen, Global Life Sciences Markets Leader, Ernst & Young, LLP
  • Networking cocktail reception

Application Details:
To apply to be a featured small business corporation and presenter, please fill out the attached application form (3–5 pages) by September 2, 2009. The top 10–15 SBIR Phase II SBIR and STTR applicants will be invited to present at the forum.

Email completed applications to Dr. Patti Weber at weberpa@mail.nih.gov.

For more information, contact Patti Weber at 301-594-8106 or Deepa Narayanan at 301-594-0212 with any questions regarding the application or the event.

Application Form and Instructions:
Guidance for Applications for NCI SBIR Investor Forum PDF File
NCI Investor Forum Application Form PDF File

This forum is sponsored by The National Cancer Institute's SBIR Development Center in collaboration with Boston University's Office of Technology Development.